AMT Medical Funding Round

4/17/2025

Venture Equity

$25,000,000

Series B

The company intends to use the funds to support new key initiatives, including CE marking and initial clinical trials in the United States in open and robotic settings.

Private & Independent

Medical Devices & Instruments

Zonneoordlaan 17
Ede, 6718 TK
The Netherlands

We have one big dream: to banish open heart bypass surgery from the world. Up until recently, that seemed a distant prospect. Well, not anymore. Today our dream becomes tangible. In the final stage, we aim for our technique to enable the bypass surgery to be performed through small holes in the chest. No split ribcage. No heart-lung machine. No stopping of the heart. Not even sutures. This means less implications during surgery and a shorter recovery time for the patient. Within a few days he or she can go home and do the things they enjoy, without pain and dysfunction. That is why we want to make this the new standard in coronary bypass surgeries, improving the quality of life for millions of people.